At the GRx+Biosims conference, FDA Commissioner Robert Califf, MD, stressed the urgent need for data transparency in the global supply chain and the role of collaboration and artificial intelligence ...
Niazi, PhD, provides an overview of the current biosimilar education material offered by the FDA, emphasizing that manufacturer-developed materials aren't needed. Number 4: Blue Shield of California ...
At the GRx+Biosims 2024 conference, a panel of industry experts and FDA officials discussed evolving device requirements for ...
At the GRx+Biosims conference, a fireside chat highlighted the need to streamline biosimilar development and strengthen ...
At the 2024 GRx+Biosims conference, industry leaders and regulatory experts underscored the urgency of unifying global ...
At the GRx+Biosims 2024 conference, panelists explored challenges and progress in biosimilar interchangeability regulations ...
Sophia Humphreys, PharmD, from Sutter Health explains that expanding biosimilars into new therapeutic areas faces hesitance ...
Sarfaraz K. Niazi, PhD, provides an overview of the current biosimilar education material offered by the FDA, emphasizing ...
Patient-Reported Outcomes Similar Between Adalimumab-adbm, Reference Product in VOLTAIRE-RA Study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback